✦ LIBER ✦

Comparison of fluorescencein situhybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients

✍ Scribed by Lin Wang; Xiaobei Wang; Xiu Nie; Ling Ma

Book ID: 107405946
Publisher: Springer-Verlag
Year: 2009
Tongue: Chinese
Weight: 428 KB
Volume: 29
Category: Article
ISSN: 0510-9752
DOI: 10.1007/s11596-009-0318-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of HER2 status between primar

Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients

✍ Erich F. Solomayer; Sven Becker; Graziella Pergola-Becker; Robert Bachmann; Bern 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 221 KB

Tissue microarray technology in the rout

Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer

✍ Jane Cryan; Anthony O’Grady; David Allen; Elaine Kay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Aneusomy 17 in Breast Cancer: Its Role i

Aneusomy 17 in Breast Cancer: Its Role in HER-2/neu Protein Expression and Implication for Clinical Assessment of HER-2/neu Status

✍ Wang, Sijian; Saboorian, M. Hossein; Frenkel, Eugene P.; Haley, Barbara B.; Sidd 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 803 KB

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i

Determination of HER2 Gene Amplification

Determination of HER2 Gene Amplification by FluorescenceIn situHybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

✍ Noël Dybdal; Grazyna Leiberman; Steven Anderson; Bryan McCune; Alex Bajamonde; R 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 237 KB

Prognostic significance of HER-2 status

Prognostic significance of HER-2 status in women with inflammatory breast cancer

✍ Shaheenah Dawood; Kristine Broglio; Yun Gong; Wei-Tse Yang; Massimo Cristofanill 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract ## BACKGROUND Inflammatory breast cancer (IBC) is a rare, aggressive form of breast cancer with poorly understood prognostic variables. The purpose of this study was to define the prognostic impact of HER‐2 status on survival outcomes of patients with IBC. ## METHODS In all, 179 pati